InvestorsHub Logo
Followers 130
Posts 23219
Boards Moderated 0
Alias Born 10/03/2016

Re: 29YEARINVESTOR post# 13439

Wednesday, 06/20/2018 7:42:17 AM

Wednesday, June 20, 2018 7:42:17 AM

Post# of 34998
Better PLPL because TXTM revenues goes to PLPL, because PLPL makes ITS money and ITS revenues through ITS South African subsidiaries?

About Plandai Biotechnology, Inc.
Plandai Biotechnology, Inc. (OTC Markets: PLPL) develops highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandai Biotechnology, through
its South African subsidiaries, controls every aspect of production, from growing specific raw materials such as green tea on its farms to producing its proprietary Phytofare extract, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. The manufacturing facility has also been engineered for citrus fruits and the recovery of limonoids. Targeted industries for the Company's products include animal husbandry, dietary supplements, diabetes and cannabis. Plandai Biotechnology is headquartered in London, United Kingdom. For more information, please visit: www.plandaibiotech.com


What are your thoughts about this?